PNC-27: A Novel Anti-Cancer Peptide Targeting HDM-2 for Selective Tumor Cell Necrosis
Discover the groundbreaking potential of PNC-27 in selectively eliminating cancer cells while preserving healthy ones.
Get a Quote & SampleProduct Core Value
PNC-27 Peptide
PNC-27 is a revolutionary anti-cancer peptide designed to offer a targeted therapeutic approach. It functions by binding to the HDM-2 protein, which is significantly expressed on the membranes of cancer cells. This specific interaction triggers the formation of transmembrane pores, leading to controlled cell death (necrosis) in cancerous cells without affecting normal, healthy cells. This unique mechanism of action, operating independently of p53 activity, positions PNC-27 as a promising agent in oncology research and development.
- Explore the PNC-27 mechanism of action to understand its selective cytotoxicity against various cancer cell lines.
- Learn about PNC-27 HDM-2 binding and how it targets tumor cell membranes for precise therapeutic intervention.
- Investigate the PNC-27 p53 independent pathway, offering a novel approach to cancer treatment not reliant on the p53 pathway.
- Discover where to buy PNC-27 peptide for your advanced research needs and contribute to cutting-edge oncology studies.
Key Advantages
Selective Cancer Cell Targeting
The primary advantage of PNC-27 lies in its precise targeting of cancer cells. By leveraging the specific expression of HDM-2 on cancer cell membranes, it ensures that therapeutic effects are concentrated where needed most, minimizing collateral damage to healthy tissues.
Induces Tumor Cell Necrosis
PNC-27 effectively induces tumor cell necrosis through pore formation. This process leads to cell death and is a key component of its anti-cancer efficacy, offering a distinct mechanism compared to traditional apoptosis-inducing agents.
P53-Independent Mechanism
A significant benefit of PNC-27 is its ability to function independently of the p53 pathway. This is crucial for cancers where p53 is mutated or absent, ensuring that the peptide's anti-cancer activity remains potent and effective.
Key Applications
Cancer Research
PNC-27 peptide research is vital for understanding novel anti-cancer mechanisms. Its unique interaction with HDM-2 offers new avenues for drug discovery and development in oncology.
Oncology Studies
As a potent agent in oncology, PNC-27 is instrumental in exploring targeted therapies. Its selective cytotoxicity provides a basis for developing more effective and less toxic cancer treatments.
Pharmaceutical Development
The development of pharmaceutical products leveraging PNC-27's properties is a key application. Its potential to be used in combination therapies or as a standalone treatment is under active investigation.
Biotechnology Innovation
PNC-27 represents a significant advancement in biotechnology, showcasing how peptide-based therapeutics can be engineered for specific biological targets, revolutionizing drug design.
Related Technical Articles & Resources
Why Choose Us?
Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.
Global Experience
With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.
Advanced Facilities
Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.
Seamless Scalability
We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).